Clinical Trial Update: Biktarvy in Treatment-Naïve Late Presenters With HIV-1 Infection [Phase 4]

View source ↗

Summary

Clinical trial update for Biktarvy in treatment-naïve late presenters with HIV-1 infection (Phase 4).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• BIKTARVY (BICTEGRAVIR SODIUM, EMTRICITABINE, AND TENOFOVIR ALAFENAMIDE FUMARATE)

Snippet

Sponsor: Peking Union Medical College Hospital | Conditions: HIV-1-infection | Phase 4 | Status: UNKNOWN